What is the AST:ALT Ratio?
AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are enzymes found primarily in the liver that help process amino acids. When liver cells are stressed or damaged, these enzymes leak into the bloodstream and can be measured with a blood test.
- AST (aspartate aminotransferase): Found in liver cells but also in muscle and heart tissue. Some AST is located in mitochondria, the energy-producing structures inside cells, which is why elevated AST can reflect deeper cellular stress.
- ALT (alanine aminotransferase): Found mostly in the liver, making it a more specific marker of liver injury.
The AST:ALT ratio compares the level of these two enzymes to help physicians interpret what may be stressing the liver.
Ratios above 2.0 may be associated with alcohol-related liver disease, while lower ratios with elevated ALT are more commonly associated with fatty liver disease and metabolic dysfunction.
Why Does AST:ALT Ratio Matter?
The liver plays a central role in metabolism, detoxification, nutrient processing, and energy regulation. Because liver disease often develops silently, changes in AST and ALT can help identify stress or injury before symptoms appear.
The AST:ALT ratio helps physicians understand what’s happening in the liver in more detail, allowing them to:
- Differentiate between causes of liver damage, including alcoholic liver disease and non-alcoholic fatty liver disease (NAFLD)
- Understand metabolic abnormalities when lipid or glucose markers appear inconsistent
- Identify early metabolic stress affecting the liver
Book your test now
Test 50+ biomarkers & meet with a longevity physician, uncover the root cause of symptoms
- HSA/FSA eligible
- Physician reviewed
- 100% satisfaction guaranteed
How to Interpret AST:ALT Ratio
(Ranges may vary slightly by lab)
Standard reference ranges represent the middle 95% of healthy individuals but don’t necessarily reflect levels associated with longevity. Optimal ranges are derived from clinical guidelines, peer-reviewed research, and real-world outcomes data, with an emphasis on levels associated with peak functioning and reduced disease risk.
What a Healthy AST:ALT Ratio Suggests
- Liver enzymes are within a pattern commonly associated with healthy liver function
- Lower likelihood of significant liver inflammation or advanced liver disease
- Lower likelihood of alcohol-related liver injury
- Reduced metabolic stress affecting the liver
Know your numbers. Own your health.
50+ biomarkers that reflect how your body is functioning — and where there’s room to optimize. Plus a clinical consult and personalized treatment plan. All for $65.
Low AST:ALT Ratio Levels
A lower AST:ALT ratio is commonly seen when ALT is higher than AST, which may occur in fatty liver disease and other metabolic conditions.
High AST:ALT Ratio Levels
A high AST:ALT ratio may suggest alcohol-related liver stress but can also occur with advanced liver fibrosis, cirrhosis, or muscle injury.
Symptoms:
- Typically asymptomatic
- Fatigue
- Jaundice (in advanced cases)
- Right-sided abdominal discomfort
Causes:
- Chronic alcohol consumption
- Liver cirrhosis and fibrosis
- Non-alcoholic fatty liver disease (NAFLD) progression
- Insulin resistance and metabolic syndrome
- Muscle injury or breakdown (rhabdomyolysis)
Healthspan Impacts:
How Hone Treats Out of Range AST:ALT Ratio
Your Hone physician will interpret the AST:ALT ratio alongside metabolic markers such as triglycerides, glucose, insulin resistance markers, and inflammatory indicators to better understand overall metabolic load on the liver. Because this ratio reflects patterns of liver stress or injury, treatment focuses on identifying and addressing the underlying cause.
- Naltrexone or acamprosate – to address alcohol use disorder
- GLP-1 agonists – emerging evidence suggests these medications may reduce liver fat and improve metabolic health in NAFLD
- Antiviral therapy* – to treat viral hepatitis
- Resmetirom* – to treat moderate-to-advanced nonalcoholic steatohepatitis
*Your Hone Physician does not prescribe these treatments but will recommend further evaluation and help coordinate care with your primary care provider when medical treatment is indicated.
- Reduce or eliminate alcohol consumption
- Eat a whole-food diet rich in fiber, antioxidants, and leafy vegetables
- Reduce refined carbohydrates, added sugars, and saturated fat
- Maintain a healthy weight (even a 7-10% body weight loss can meaningfully improve liver enzyme levels)7
- Engage in regular aerobic and resistance training
- Avoid unnecessary use of medications that stress the liver (NSAIDs)
Xuan, Y., et al. (2024). Elevated ALT/AST ratio as a marker for NAFLD risk and severity: Insights from a cross-sectional analysis in the United States. Frontiers in Endocrinology.
↑Chen, W., et al. (2022). Elevated AST/ALT ratio is associated with all-cause mortality and cancer incident. Journal of clinical laboratory analysis.
↑Liu, X., & Liu, P. (2022). Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: A secondary analysis based on a retrospective cohort study. Scientific Reports.
↑Mirhashemi, S.H., et al. (2022). Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery. Metabolism Open.
↑Nejati, L., et al. (2022). The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial. Medical Journal of the Islamic Republic of Iran.
↑Aziz, T., et al. (2024). Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Cureus.
↑Brunner, K.T., et al. (2019). Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports.
↑
Reviewed for Accuracy by Our Medical Review Board
This biomarker information has been reviewed by a member of Hone’s medical review board. As part of the medical review team, physicians fact-check this content against the latest research and their own experience treating their patients.
Ashley Winter, M.D., is a board-certified urogynecologist trained at Weill Cornell and Cleveland Clinic. She specializes in female and male sexual dysfunction, urinary issues, genital pain, and hormone therapy.
James Staheli, D.O., is the Medical Director for Broad Health, Hone Health’s affiliated medical practice and a family medicine doctor in Atlanta, Georgia.
